Sign In
Buy NXL
$0.533
-0.0175 (-3.18%)
At Close: Jun 03, 2026
Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment
09:00am, Thursday, 05'th Sep 2024
Meeting showcases the potential role of Nexalin's neurostimulation technology in revolutionizing opioid treatment through virtual care solutions Meeting showcases the potential role of Nexalin's neuro
Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
09:55am, Friday, 26'th Jul 2024
ORLANDO, FL / ACCESSWIRE / July 26, 2024 / RedChip Companies will air interviews with Nexalin Technology, Inc. (Nasdaq:NXL) and LOBO EV Technologies Ltd. (Nasdaq:LOBO) on the RedChip Small Stocks, Big
Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery
08:30am, Thursday, 18'th Jul 2024
‘Breaking Barriers' Coalition Formed to Address Opioid Use Disorder in the USA Nexalin CEO Mark White Participates in Inaugural Meeting HOUSTON, TX, July 18, 2024 (GLOBE NEWSWIRE) -- Nexalin Technol
Nexalin Technology Announces Closing of $5.2 Million Public Offering
02:45pm, Monday, 01'st Jul 2024
HOUSTON, TX, July 01, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced the closing of its previously announced public offeri
The 3 Smartest Penny Stocks to Buy With Your Money Right Now
06:31am, Monday, 01'st Jul 2024
Penny stocks are risky and are known for crashing and burning fast. Most of these stocks are unstable and attract a lot of speculations and shifts in the market.
Why Is Nexalin Technology (NXL) Stock Down 35% Today?
08:31am, Friday, 28'th Jun 2024
Nexalin Technology (NASDAQ: NXL ) stock is down on Friday after the medical device company priced a public offering of its shares. Nexalin Technology is selling 3 million shares of NXL stock for $1.7
Nexalin Technology Announces Pricing of $5.2 Million Public Offering
09:15pm, Thursday, 27'th Jun 2024
HOUSTON, TX, June 27, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced the pricing of a public offering of 3,000,000 shares
HOUSTON, TEXAS, June 20, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced that the United States Patent and Trademark Office
Why Is Nexalin Technology (NXL) Stock Down 29% Today?
08:21am, Friday, 14'th Jun 2024
Nexalin Technology (NASDAQ: NXL ) stock is retreating on Friday after the medical device company's shares underwent a massive rally late yesterday. That rally came alongside regulatory approval of on
Brazil represents the 9th largest economy in the world with more than 35 million afflicted by mental health disorders Brazil represents the 9th largest economy in the world with more than 35 million a
Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th
08:30am, Tuesday, 04'th Jun 2024
HOUSTON, TX, June 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced today that it will be participating in the Spring MicroCap R
Clinical studies in anxiety and insomnia expected to commence in the third quarter of 2024 Clinical studies in anxiety and insomnia expected to commence in the third quarter of 2024
Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts
08:30am, Wednesday, 22'nd May 2024
HOUSTON, TX, May 22, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) is pleased to announce its new division, Nexalin America, has been sele
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
10:44am, Thursday, 25'th Apr 2024
HOUSTON, TEXAS, April 25, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock M
Nexalin Technology CEO Provides Letter to Shareholders
08:30am, Wednesday, 10'th Apr 2024
Reports on growing clinical data supporting its neurostimulation technology and progress advancing its new Gen-3 HALO™ Clarity Virtual Clinic model Reports on growing clinical data supporting its n
